Polymeric tubulysin-peptide nanoparticles with potent antitumor activity.
about
Broad targeting of angiogenesis for cancer prevention and therapyCurrent Advances of Tubulin Inhibitors in Nanoparticle Drug Delivery and Vascular Disruption/AngiogenesisNovel polymeric nanoparticles for intracellular delivery of peptide Cargos: antitumor efficacy of the BCL-2 conversion peptide NuBCP-9Intracellular Targeting of the Oncogenic MUC1-C Protein with a Novel GO-203 Nanoparticle FormulationTumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas.Cochinchina momordica seed extract induces apoptosis and cell cycle arrest in human gastric cancer cells via PARP and p53 signal pathways.Nanoparticle delivery of a peptide targeting EGFR signalingChemotherapeutic evaluation of a synthetic tubulysin analogue-dendrimer conjugate in c26 tumor bearing miceAnti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives.Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements.Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspectiveBest practices in cancer nanotechnology: perspective from NCI nanotechnology alliance.Clinical developments in nanotechnology for cancer therapy.Peptide-mediated cancer targeting of nanoconjugates.Cyclodextrin-containing polymers: versatile platforms of drug delivery materials.Nanoparticles as delivery carriers for anticancer prodrugs.Chemistry and biology of tubulysins: antimitotic tetrapeptides with activity against drug resistant cancers.Soft Supramolecular Nanoparticles by Noncovalent and Host-Guest Interactions.Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy.Peptide nanostructures in biomedical technology.Carbohydrate-based amphiphilic nano delivery systems for cancer therapy.Structural recognition of tubulysin B derivatives by multidrug resistance efflux transporters in human cancer cells.KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation.Synthesis and Superpotent Anticancer Activity of Tubulysins Carrying Non-hydrolysable N-Substituents on Tubuvaline.
P2860
Q27002903-7FFEA40F-4DFC-453C-A18F-6FB4EB248845Q28077780-32AE45A5-C0C3-4013-9E69-4061B4ADCAE0Q28389837-C0191DB9-A8F0-473F-91D9-36D96893FDFCQ28394194-FAC6B6F8-2C89-4DED-A511-DDC48816E529Q33837621-6921B31C-2196-4C5D-9E4B-AB10F0893C21Q34423766-574741E3-A6F3-4083-8BAE-A2EA72F43EA4Q35589627-9681FBD4-D442-444F-BD1C-95E4B3147A63Q36315671-B3F217D1-FD15-4D55-BD6D-E5724348FEC2Q36382953-83432072-8D2E-4704-804F-F04BFDDE5804Q37245063-59030CE3-7315-45C4-A6E0-93A563B65B27Q37454370-6ABDC481-60D2-4936-BBB7-156E62F58CDFQ37561973-A52D3ABB-EDE5-425E-B680-3B2CBD10AE6DQ37765187-7FC4366A-D88F-4ECD-8EDE-C4382BC91851Q37806710-C4E29C59-BEF6-4993-ADF7-922F28BCEEEFQ38002033-52AD5D42-0A1E-4364-9902-8F22E6D2B3EBQ38002956-F2A97D8F-AF82-433B-988B-AAC76E21FEEEQ38354179-F1C3D47E-5E76-469B-9B76-5332C77F2C3CQ38638661-32ABE1D0-E5BF-4926-B216-517D3CA7BFD1Q38648690-C0E1923E-EDD6-45BA-A0BC-E48E6F86D6CAQ38723306-54187D7C-7351-40C0-89AE-F9D0BF4ACAA3Q38974572-EE7BC9F5-D284-405A-8CEF-0D00B165A1A4Q41472858-53FF23F4-4081-48BB-8606-F57F530F7051Q42107713-9CE796DD-4171-4945-84AF-8ED1CF2DE63AQ48117054-A7226C5B-4A82-438D-8C1B-958134B58A9A
P2860
Polymeric tubulysin-peptide nanoparticles with potent antitumor activity.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Polymeric tubulysin-peptide nanoparticles with potent antitumor activity.
@en
Polymeric tubulysin-peptide nanoparticles with potent antitumor activity.
@nl
type
label
Polymeric tubulysin-peptide nanoparticles with potent antitumor activity.
@en
Polymeric tubulysin-peptide nanoparticles with potent antitumor activity.
@nl
prefLabel
Polymeric tubulysin-peptide nanoparticles with potent antitumor activity.
@en
Polymeric tubulysin-peptide nanoparticles with potent antitumor activity.
@nl
P2093
P1476
Polymeric tubulysin-peptide nanoparticles with potent antitumor activity.
@en
P2093
Gregory S Jensen
Julienne Duringer
Jungyeong Hwang
Paula Gunawan
Steven Hinton
Thomas Schluep
Wolfgang Richter
P304
P356
10.1158/1078-0432.CCR-08-1848
P407
P577
2009-01-01T00:00:00Z